Reducing Acute Kidney Injury Occurence by Administering Angiotensin II

NCT05199493 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Surgery
Vasoplegia
Hyperreninemia

Interventions

DRUG: Angiotensin II
DRUG: Control

Sponsor

Universität Münster

Collaborators

[object Object]